The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugita, S.
Right arrow Articles by Streilein, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugita, S.
Right arrow Articles by Streilein, J. W.
The Journal of Immunology, 2006, 176: 118-127.
Copyright © 2006 by The American Association of Immunologists

B7+ Iris Pigment Epithelium Induce CD8+ T Regulatory Cells; Both Suppress CTLA-4+ T Cells1,2

Sunao Sugita*,{ddagger}, Tat Fong Ng*, Philip J. Lucas{dagger}, Ronald E. Gress{dagger} and J. Wayne Streilein3,*

* Department of Ophthalmology, Schepens Eye Research Institute, Harvard Medical School, Boston, MA 02114; {dagger} Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; and {ddagger} Department of Ophthalmology & Visual Science, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan

Ocular pigment epithelia contribute to immune privilege by suppressing T cell activation and converting T cells into regulatory T regulatory cells (Tregs) that inhibit bystander T cell activation. Iris pigment epithelium (IPE) does so through direct cell-cell contact with naive T cells, and this suppressive contact is via interactions between B7 expressed constitutively on IPE cells and CTLA-4 expressed on a subpopulation of CD8+ T cells. We have now examined whether TGF{beta} is required in this process. We report that IPE produces both soluble and membrane-bound active TGF{beta}, but that only the latter is actually delivered to CD8+ T cells. In turn, these T cells become IPE Tregs by up-regulating their own expression of B7-1/B7-2 and soluble and membrane-bound TGF{beta}. IPE Tregs through their expression of B7 are able to engage CTLA-4+ bystander T cells, and thus precisely, target delivery of membrane-bound TGF{beta}. We propose that this mechanism of suppression via TGF{beta} ensures that soluble active TGF{beta} is not released into the ocular microenvironment where it can have unregulated and deleterious effects, including elevation of intraocular pressure and development of glaucoma.




This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Futagami, S. Sugita, J. Vega, K. Ishida, H. Takase, K. Maruyama, H. Aburatani, and M. Mochizuki
Role of Thrombospondin-1 in T Cell Response to Ocular Pigment Epithelial Cells
J. Immunol., June 1, 2007; 178(11): 6994 - 7005.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Stein-Streilein and A. W. Taylor
An eye's view of T regulatory cells
J. Leukoc. Biol., March 1, 2007; 81(3): 593 - 598.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Sugita, H. Keino, Y. Futagami, H. Takase, M. Mochizuki, J. Stein-Streilein, and J. W. Streilein
B7+ Iris Pigment Epithelial Cells Convert T Cells into CTLA-4+, B7-Expressing CD8+ Regulatory T Cells
Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5376 - 5384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.